Revance Therapeutics Shares Are Trading Lower After the Company Announced a Proposed Public Offering of $100 Million of Its Common Stock
Revance Therapeutics宣佈擬公開發行1億美元普通股後,該公司股價走低
Revance Therapeutics Shares Are Trading Lower After the Company Announced a Proposed Public Offering of $100 Million of Its Common Stock
Revance Therapeutics宣佈擬公開發行1億美元普通股後,該公司股價走低
使用瀏覽器的分享功能,分享給你的好友吧